Publications by authors named "Anne Favret"

Claim this Profile
E
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Denise A Yardley, Lowell Hart, Anne Favret, Sibel Blau, Sami Diab

Clin Breast Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Gabe S Sonke, Lowell L Hart, Mario Campone, Frans Erdkamp, Wolfgang Janni, Anne M Favret

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
Joanne L Blum, Nicholas Robert, Jay Andersen, Anne Favret, Patrick Ward

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Denise A Yardley, James Reeves, E Claire Dees, Cynthia Osborne, Devchand Paul, Anne Favret

Clin Breast Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
Gabriel N Hortobagyi, Salomon M Stemmer, Howard A Burris, Yoon-Sim Yap, Gabe S Sonke, Anne M Favret

N Engl J Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
Neelima Denduluri, Debra A Patt, Yunfei Wang, Menaka Bhor, Xiaoyan Li, Anne M Favret

J Natl Compr Canc Netw· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Stephen E Jones, Rufus Collea, Devchand Paul, Scot Sedlacek, Anne M Favret

Lancet Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensity in early-stage breast cancer: a community practice experience.
Robert L Bretzel, Ralph Cameron, Marc Gustas, Maria A Garcia, Heather K Hoffman, Anne Favret

J Oncol Pract· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-positive advanced breast cancer.
Nicholas J Robert, Anne M Favret

Hematol Oncol Clin North Am· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary Management of Locally Advanced Breast Cancer.
Robert W. Carlson, Anne M. Favret

Breast J· September 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis